A

ATAI Life Sciences NV
D

ATAI

3.90500
USD
-0.15
(-3.70%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
1,418,353,021
الأخبار المقالات

العنوان: Atai Beckley NV

القطاع: Healthcare
الصناعة: Biotechnology
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.